Daniel-Ulloa Jason, Gilbert Paul A, Parker Edith A
The authors are with University of Iowa, College of Public Health; and University of Iowa Prevention Research Center, Cancer Prevention and Control Research Network, Iowa City.
Am J Public Health. 2016 Apr;106(4):746-7. doi: 10.2105/AJPH.2015.303039. Epub 2016 Feb 18.
To assess national differences in human papillomavirus (HPV) vaccine uptake among young adults in the United States by gender, race/ethnicity, and sexual orientation.
We tested group differences in initiation and completion of the HPV vaccine series (i.e., 3 doses) by Rao-Scott χ(2) test among 6444 respondents aged 18 to 30 years from the 2013 National Health Interview Survey.
Among men, 5% reported receiving the HPV vaccine, with no differences in uptake by race/ethnicity or sexual orientation. By contrast, 30% of the women reported receiving the HPV vaccine, with women of color having lower odds of initiating and completing the vaccine series compared with White women.
In the United States, HPV vaccine rates are lagging in men and show disparities among women. Increasing HPV vaccine uptake and series completion among women of color and all men may provide considerable long-term public health benefits.
按性别、种族/族裔和性取向评估美国年轻人中人类乳头瘤病毒（HPV）疫苗接种率的国家差异。
我们通过Rao-Scott卡方检验，对2013年国家健康访谈调查中6444名年龄在18至30岁的受访者进行HPV疫苗系列（即3剂）起始接种和完成接种情况的组间差异测试。
在男性中，5%报告接种了HPV疫苗，种族/族裔或性取向对接种率无差异。相比之下，30%的女性报告接种了HPV疫苗，有色人种女性起始接种和完成疫苗系列的几率低于白人女性。
在美国，HPV疫苗接种率在男性中滞后，在女性中存在差异。提高有色人种女性和所有男性的HPV疫苗接种率及系列完成率可能会带来可观的长期公共卫生效益。
